ArticleJournal of managed care & specialty pharmacy2019

Cost-Effectiveness of Sarilumab Added to Methotrexate in the Treatment of Adult Patients with Moderately to Severely Active Rheumatoid Arthritis Who Have Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors.

Noemi Muszbek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.